QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Activity

15 hedge funds and large institutions have $6.28M invested in Qualigen Therapeutics in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.

Holders
15
Holders Change
+7
Holders Change %
+87.5%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
7
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$1.77M
2
KCM
2
Knoll Capital Management
Florida
$2.58M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$339K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$80K
5
BFA
5
BlackRock Fund Advisors
California
$134K

Top Sellers

1
TMC
1
Trellus Management Company
Florida
$46K
Name Market Value Shares Shares
Change 		Shares
Change %
KCM
1
Knoll Capital Management
Florida
$2.58M 952,434 +425,531 +81%
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$1.77M 652,285 +652,285 New
BBA
3
Baker Bros. Advisors
New York
$1.08M 400,000 – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$339K 124,989 +64,859 +108%
BFA
5
BlackRock Fund Advisors
California
$134K 49,579 +10,800 +28%
Creative Planning
6
Creative Planning
Kansas
$100K 37,000 – –
VKH
7
Virtu KCG Holdings
New York
$80K 29,363 +10,116 +53%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$80K 29,614 +29,614 New
TMC
9
Trellus Management Company
Florida
$46K 17,000 -500 -3%
AL
10
Agran Libbie
California
$28K 10,500 – –
Wells Fargo
11
Wells Fargo
California
$14K 5,000 +5,000 New
AIM
12
Acrospire Investment Management
Illinois
$13K 4,925 +4,925 New
UBS Group
13
UBS Group
Switzerland
$9K 3,402 +3,402 New
Citigroup
14
Citigroup
New York
$1K 369 +369 New
Bank of America
15
Bank of America
North Carolina
$0 1 +1 New